Kelly Culwell Evofem Biosciences, Inc. (EVFM) insider trading activity
Kelly Culwell is Chief Medical Officer of Evofem Biosciences, Inc.. Currently has a direct ownership of 273,390 shares of EVFM, which is worth approximately $2,733. The most recent transaction as insider was on May 20, 2021, when has been sold 42,061 shares (Common Stock) at a price of $0.86 per share, resulting in proceeds of $36,172. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
273K
0%
3M change
0%
12M change
Total Value Held
$2,733
Kelly Culwell Transaction History
KC
Kelly Culwell
Chief Medical Officer
San Diego, CA